XOMA Corp

NASDAQ XOMAP

Data sourced from iex and EODHD
Download Data

XOMA Corp Liabilities to Equity Ratio for the quarter ending March 31, 2024: 1.66

XOMA Corp Liabilities to Equity Ratio is 1.66 for the quarter ending March 31, 2024, a 896.24% change year over year. The liabilities to equity ratio, also known as the leverage ratio, measures the proportion of a company's total liabilities to its shareholders' equity. It is calculated by dividing the total liabilities by the shareholders' equity. This ratio provides insights into the extent to which a company relies on debt financing compared to equity financing. A higher ratio indicates higher financial leverage, which can amplify both returns and risks for the company's shareholders.
  • XOMA Corp Liabilities to Equity Ratio for the quarter ending March 31, 2023 was 0.17.
NASDAQ: XOMAP

XOMA Corp

CEO -
IPO Date Dec. 16, 2020
Location United States
Headquarters 2200 Powell Street, EmeryVille, CA, United States, 94608
Employees 13
Sector Healthcare
Industry Biotechnology
Description

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Similar companies

XOMAO

XOMA Corporation

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email